Hampus Olsson

Associate
  • Gothenburg
  • Languages:
    Swedish, English

Education

  • Lund University, LL.M, 2018

Experience

  • Summer Associate, Advokatfirman Vinge, 2017

Mandate

Mandate March 12, 2021

Vinge has advised CELLINK in connection with directed issues of SEK 3 billion

Vinge has advised CELLINK AB (publ) in connection with a directed issue of covertibles of SEK 1.5 bi…

Mandate March 11, 2021

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate January 26, 2021

Vinge has advised EQT in connection with the combination with Exeter Property Group

Vinge has advised EQT in connection with the signing of a combination with Exeter Property Group, a…

Mandate July 13, 2020

Vinge advises Hansa Biopharma in connection with a directed share issue

The board of directors of Hansa Biopharma has, on the basis of an authorisation granted from the ann…

Mandate June 10, 2020

Vinge advises Calliditas

Vinge advises Calliditas Therapeutics in connection with its capital raising and listing on The Nasd…

Mandate June 04, 2020

Vinge advises Nanoform in connection with its capital raising and listing on Nasdaq First North Premier Growth markets Finland and Sweden

Vinge has advised Nanoform Finland Plc (“Nanoform”) in connection with its capital raising and listi…

Mandate May 11, 2020

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate January 10, 2020

Vinge has advised Industrifonden and Investinor in connection with a sale of shares in Calliditas

Vinge has advised Industrifonden and Investinor in connection with a sale of in total approximately…

Mandate November 06, 2019

Vinge has advised Pandox in connection with a directed share issue of approximately SEK 3 billion

Vinge has advised the hotel property owner Pandox in connection with a directed share issue of 16,35…

Mandate September 24, 2019

Vinge has advised EQT AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockh…

Mandate September 09, 2019

Vinge acts for SUSI Partners on its acquisition of the Lyngsåsa wind park

Vinge has acted for SUSI Partners, manager of the SUSI Renewable Energy Fund II, in connection with…

Mandate June 28, 2019

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate June 11, 2019

Vinge advises Compass Group on the acquisition of Fazer Food Services from Fazer Group

Fazer Food Services is a renowned food catering business in the Nordic region with operations in Fin…

Mandate May 16, 2019

Vinge has advised Coop in connection with the acquisition of Netto’s Swedish grocery stores

Vinge has advised Coop Butiker & Stormarknader AB in connection with the acquisition of Netto’s Swed…

Mandate April 26, 2019

Vinge advises Colliers International Group Inc.

Vinge has advised Colliers International Group Inc. in connection with its acquisition of the Swedis…

Mandate April 25, 2019

Vinge advises Finanzero Brazil in connection with capital raising

Vinge advises Finanzero in connection with the company's capital raising of approximately SEK 100 mi…

Mandate March 28, 2019

Vinge advises Lantmännen in conjunction with acquisition from Tate&Lyle

Vinge has advised Lantmännen in connection with its acquisition of British Tate&Lyle’s Swedish o…

Mandate February 07, 2019

Vinge advises STMicroelectronics on its acquisition of a majority stake in Norstel AB

Vinge has advised the French-Italian electronics and semiconductor manufacturer STMicroelectronics i…

Mandate January 25, 2019

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…

Mandate May 24, 2018

Vinge advises IRLAB Therapeutics in connection with a directed share issue

The board of directors of IRLAB Therapeutics has, on the basis of an authorisation granted from the…

Mandate April 05, 2018

Vinge advises Finanzero in connection with capital raising

Vinge advises Finanzero in connection with the company's capital raising of approximately SEK 30 mil…

Mandate March 30, 2018

Vinge advises Stendörren Fastigheter in connection with its listing on Nasdaq Stockholm

Vinge advises Stendörren Fastigheter AB (publ) in connection with its list change from Nasdaq First…

Mandate March 23, 2018

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncop…